HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simultaneous heart-kidney transplantation results in respectable long-term outcome but a high rate of early kidney graft loss in high-risk recipients - a European single center analysis.

AbstractBACKGROUND:
In spite of renal graft shortage and increasing waiting times for transplant candidates, simultaneous heart and kidney transplantation (HKTx) is an increasingly performed procedure established for patients with combined end-stage cardiac and renal failure. Although data on renal graft outcome in this setting is limited, reports on reduced graft survival in comparison to solitary kidney transplantation (KTx) have led to an ongoing discussion of adequate organ utilization.
METHODS:
This retrospective study was conducted to evaluate prognostic factors and outcomes of 27 patients undergoing HKTx in comparison to a matched cohort of 27 patients undergoing solitary KTx between September 1987 and October 2019 in one of Europe's largest transplant centers.
RESULTS:
Median follow-up was 100.33 (0.46-362.09) months. Despite lower five-year kidney graft survival (62.6% versus 92.1%; 111.73 versus 183.08 months; p = 0.189), graft function and patient survival (138.90 versus 192.71 months; p = 0.128) were not significantly inferior after HKTx in general. However, in case of prior cardiac surgery requiring sternotomy we observed significantly reduced early graft and patient survival (57.00 and 94.09 months, respectively) when compared to patients undergoing solitary KTx (183.08 and 192.71 months; p < 0.001, respectively) or HKTx without prior cardiac surgery (203.22 and 203.22 months; p = 0.016 and p = 0.019, respectively), most probably explained by the significantly increased rate of primary nonfunction (33.3%) and in-hospital mortality (25.0%).
CONCLUSIONS:
Our data demonstrates the increased rate of early kidney graft loss and thus significantly inferior graft survival in high-risk patients undergoing HKTx. Thus, we advocate for a "kidney-after-heart" program in such patients to ensure responsible and reasonable utilization of scarce resources in times of ongoing organ shortage crisis.
AuthorsOliver Beetz, Juliane Thies, Clara A Weigle, Fabio Ius, Michael Winkler, Christoph Bara, Nicolas Richter, Jürgen Klempnauer, Gregor Warnecke, Axel Haverich, Murat Avsar, Gerrit Grannas
JournalBMC nephrology (BMC Nephrol) Vol. 22 Issue 1 Pg. 258 (07 09 2021) ISSN: 1471-2369 [Electronic] England
PMID34243724 (Publication Type: Journal Article)
Copyright© 2021. The Author(s).
Chemical References
  • Immunosuppressive Agents
Topics
  • Adult
  • Aged
  • Female
  • Germany
  • Graft Survival
  • Heart Transplantation (adverse effects, mortality)
  • Hospital Mortality
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Kidney Transplantation (adverse effects, mortality)
  • Male
  • Middle Aged
  • Postoperative Complications
  • Retrospective Studies
  • Risk Factors
  • Schools, Medical
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: